Summary of medicine characteristics - DULBALM CREAM
1 NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORMCream
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
External application for the symptomatic treatment of muscle stiffness, muscular rheumatism, lumbago, sciatica, fibrositis, sprains and chilblains.
4.2. Posology and method of administration
Apply externally with gentle massage 2 – 3 times daily, avoiding broken or inflamed skin.
DO NOT APPLY TO CHILDREN UNDER 6 YEARS OF AGE.
4.3. Contra-indications
Known sensitivity to any of the ingredients.
Do not apply to children less than six years old.
4.4. Special warnings and precautions for use
Do not apply to broken or tender skin.
Application on mucous membranes should be avoided.
Discontinue if rash develops.
Not for use with occlusive dressings.
Topical application may result in systemic effects, including asthma.
Patients should be advised against excessive exposure of areas treated to sunlight, in order to avoid possibility of photosensitivity.
Keep away from eyes.
Wash hands after use.
4.5. Interactions with other medicinal products and other forms of interaction
None known.
4.6. Pregnancy and lactation
As with most medicines, use in pregnancy or breastfeeding should be avoided.
4.7. Effects on ability to drive and use machines
Not applicable.
4.8. Undesirable effects
Photosensitivity and application site reactions.
4.9. Overdose
4.9. OverdoseNot applicable.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
All the active ingredients in Dulbalm Cream are topical vasodilators with rubifacient activity.
5.2. Pharmacokinetic properties
External application of Dulbalm Cream to intact skin results in negligible systemic absorption.
5.3. Preclinical safety data
5.3. Preclinical safety dataNot applicable.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Emulsifying Wax, White Soft Paraffin, Polysorbate 80, Cineole, Purified Water.
6.2. Incompatibilities
None known.
6.3. Shelf life
36 months.
6.4. Special precautions for storage
6.4. Special precautions for storageStore between 4°C and 25°C.
Keep all medicines out of the reach of children.
6.5. Nature and contents of container
Aluminium tube, 25g.
6.6. Instruction for use/handling
No special handling is required.
7 MARKETING AUTHORISATION HOLDER
Norma Chemicals Ltd.
51–53 Stert Street
Abingdon
Oxfordshire OX14 3JF
United Kingdom
8. MARKETING AUTHORISATION NUMBER
PL 00386/5007R
9. DATE OF FIRST AUTHORISATION/RENEWAL OF
AUTHORISATION
29 December 1983 / 28 February 1995